{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19405508", "DateCompleted": {"Year": "2010", "Month": "07", "Day": "20"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1021/np8006342"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "72", "Issue": "5", "PubDate": {"Year": "2009", "Month": "May", "Day": "22"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii.", "Pagination": {"StartPage": "805", "EndPage": "812", "MedlinePgn": "805-12"}, "Abstract": {"AbstractText": ["Cytotoxicity-guided fractionation of an organic solvent extract of the plant Crossosoma bigelovii led to the discovery of a new strophanthidin glycoside (1) and two new 2-methylchromone glycosides (2 and 3). Also isolated were the known chromones eugenin and noreugenin, the indole alkaloid ajmalicine, the dibenzylbutane lignan secoisolariciresinol, the dibenzylbutyrolactone lignan matairesinol, and the furanone 5-tetradec-5-enyldihydrofuran-2-one. Further investigation into the biological properties of strophanthidin glycosides revealed a connection between inhibition of HIF-1 activation and the glycosylation of the genin. This work is the first published study of the bioactive phytochemicals of the family Crossosomataceae."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Support Group, SAIC-Frederick, Inc, NCI-Frederick, Frederick, Maryland 21702, USA."}], "Identifier": [], "LastName": "Klausmeyer", "ForeName": "Paul", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Qin", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Scudiero", "ForeName": "Dominic A", "Initials": "DA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Uranchimeg", "ForeName": "Badarch", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Melillo", "ForeName": "Giovanni", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cardellina", "ForeName": "John H", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shoemaker", "ForeName": "Robert H", "Initials": "RH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chang", "ForeName": "Ching-Jer", "Initials": "CJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "McCloud", "ForeName": "Thomas G", "Initials": "TG"}], "GrantList": [{"GrantID": "N01-CO-12400", "Acronym": "CO", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01-CA-49632", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3beta-((O-beta-D-glucopyranosyl-(1-3)-4,6-dideoxy-2-O-methyl-beta-D-glucopyranosyl))-5beta,14beta-dihydroxy-19-oxocard-20(22)enolide"}, {"RegistryNumber": "0", "NameOfSubstance": "5-hydroxy-2-methylchromone-7-O-rutinoside"}, {"RegistryNumber": "0", "NameOfSubstance": "5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Butylene Glycols"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardenolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromones"}, {"RegistryNumber": "0", "NameOfSubstance": "Furans"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "580-72-3", "NameOfSubstance": "matairesinol"}, {"RegistryNumber": "M8QRJ7JEJH", "NameOfSubstance": "secoisolariciresinol"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Butylene Glycols"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Cardenolides"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Chromones"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Furans"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": [], "DescriptorName": "HT29 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors", "drug effects"], "DescriptorName": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"QualifierName": ["chemistry", "isolation & purification"], "DescriptorName": "Lignans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Magnoliopsida"}, {"QualifierName": [], "DescriptorName": "Mexico"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Nuclear Magnetic Resonance, Biomolecular"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2010", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19405508", "10.1021/np8006342"]}}], "PubmedBookArticle": []}